Pyrethroid pesticide exposure and parental report of learning disability and attention-deficit hyperactivity disorder in U.S. children: NHANES 1999-2002. by Quiros-Alcala, Lesliam et al.
    
 
Environmental Health Perspectives doi:10.1289/ehp.1308031
Supplemental Material 
Pyrethroid Pesticide Exposure and Parental Report of Learning 
 
Disability and Attention Deficit/Hyperactivity Disorder in U.S. 
 
Children: NHANES 1999–2002 
 
Lesliam Quirós-Alcalá, Suril Mehta, and Brenda Eskenazi
  
  
    
   
  
    
  
    
  
     
  
     
  
     
  
     
        
        
        
        
        
         
         
         
        
        
         
         
        
        
         
        
            
          
         
          
        
           
        
        
        
        
        
        
        
        
        
        
             
        
        
        
           
        
        
        
Table S1. Demographic/personal characteristics and environmental factors for study participants with and without pyrethroid metabolite data [n (%)].a 
Children's characteristics All children
n = 4672
Children with
3-PBA (n = 1861)
Children without
3-PBA (n = 2811)
Children with
cis-DCCA (n = 1839)
Children without
cis-DCCA (n = 2833)
Children with
trans-DCCA (n = 1848)
Children without
trans-DCCA (n = 2824)
Gender
Male 2308 (51.4) 899 (51.7) 1409 (52.1) 885 (51.4) 1423 (52.2) 891 (51.6) 1417 (52.1)
Female 2364 (48.6) 962 (48.3) 1402 (47.9) 954 (48.6) 1410 (47.8) 957 (48.4) 1407 (47.9)
Missing 0 0 0 0 0 0 0
Race/ethnicity
Non-Hispanic White 1201 (60.0) 466 (58.5) 735 (61.7) 460 (58.5) 741 (61.7) 462 (58.4) 739 (61.7)
Non-Hispanic Black 1450 (14.9) 596 (14.6) 854 (14.3) 594 (14.7) 856 (14.2) 590 (14.5) 860 (14.3)
Mexican American 1639 (11.6) 625 (11.3) 1014 (11.8) 612(11.1) 1027(11.9) 623 (11.4) 1016 (11.7)
Other 383 (13.5) 174 (15.7) 208 (12.2) 173 (15.7) 209 (12.2) 173 (15.7) 209 (12.2)
Missing 0 0 0 0 0 0 0
Poverty-income-ratio (PIR)
< 0.94 1323 (21.7) 549 (22.9) 774 (20.6) 540 (22.7) 783 (20.7) 542 (22.7) 781 (20.7)
0.94-1.80 1096 (23.5) 441 (24.0) 655 (23.0) 435 (23.9) 661 (23.0) 439 (24.0) 657 (23.0)
1.81-3.56 992 (27.1) 387 (25.9) 605 (28.1) 382 (25.9) 610 (28.1) 384 (25.9) 608 (28.1)
> 3.56 810 (27.7) 318 (27.2) 492 (28.4) 317 (27.5) 493 (28.2) 318 (27.4) 492 (28.2)
Missing 451 166 285 165 286 165 286
Household reference person's education level
< High school 1750 (24.2) 688 (24.7) 1062 (23.9) 678 (24.7) 1072 (23.8) 683 (24.7) 1067 (23.8)
High school 1113 (27.7) 438 (25.9) 675 (28.8) 431 (25.6) 682 (29.1) 434 (25.7) 679 (29.0)
> High school 1637 (48.1) 663 (49.4) 974 (47.3) 658 (49.7) 979 (47.1) 659 (49.6) 978 (47.2)
Missing 172 72 100 72 100 72 100
Low birth weight (< 2500g)
Yes 397 (7.5) 160 (7.4) 239 (7.7) 155 (7.3) 242 (7.7) 157 (7.3) 240 (7.6)
No 4077 (92.5) 1629 (92.6) 2446 (92.3) 1613 (92.7) 2464 (92.3) 1621 (92.7) 2456 (92.4)
Missing 198 72 126 (4.5) 71 127 70 128
Age
6-7 years 751 (21.0) 333 (19.8) 418 (20.2) 326 (19.5) 425 (20.4) 329 (19.6) 422 (20.3)
8-9 years 771 (19.7) 377 (20.4) 394 (17.3) 374 (20.5) 397 (17.3) 277 (20.5) 394 (17.2)
10-11 years 737 (19.7) 339 (18.3) 398 (18.9) 334 (18.3) 403 (18.9) 334 (18.2) 403 (19.0)
12-13 years 1251 (20.0) 411 (20.6) 840 (22.2) 406 (20.6) 845 (22.1) 408 (20.1) 843 (22.1)
14-15 years 1162 (19.6) 401 (20.9) 761 (21.4) 399 (21.1) 763 (21.3) 400 (21.1) 762 (21.3)
Missing 0 0 0 0 0 0 0
Neonatal intensive care unit (NICU) admission
Yes 516 (11.7) 205 (12.0) 311 (11.3) 204 (12.1) 312 (11.3) 203 (12.0) 313 (11.3)
No 4115 (88.3) 1641 (88.0) 2474 (88.7) 1620 (87.9) 2495 (88.7) 1630 (88.0) 2485 (88.7)
Missing 41 15 26 15 26 15 26
Attended daycare or preschool
Yes 3077 (72.9) 1229 (71.6) 1848 (73.9) 1219 (71.9) 1858 (73.7) 1224 (72.0) 1853 (73.6)
No 1588 (27.1) 630 (28.4) 958 (26.1) 618 (28.1) 970 (26.3) 622 (28.0) 966 (26.4)
Missing 7 2 5 2 5 2 5
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Children's characteristics All children
n = 4672
Children with
3-PBA (n = 1861)
Children without
3-PBA (n = 2811)
Children with
cis-DCCA (n = 1839)
Children without
cis-DCCA (n = 2833)
Children with
trans-DCCA (n = 1848)
Children without
trans-DCCA (n = 2824)
Health insurance
Yes 3774 (81.2) 1492 (82.8) 2282 (88.7) 1474 (82.7) 2300 (88.7) 1479 (82.7) 2295 (88.7)
No 837 (13.8) 348 (17.2) 489 (11.3) 344 (17.3) 493 (11.3) 348 (17.3) 489 (11.3)
Missing 61 21 40 21 40 21 40
Total DAPs
< 3.15 x 10-8 mol/L 517 (30.3) 517 (30.5) 0 512(30.3) 5 (60.1) 515 (30.4) 2 (46.5)
3.15 x 10-8 to 1.14 x 10-7mol/L 594 (31.0) 594 (31.1) 0 589 (31.2) 5 (15.3) 592 (31.2) 2 (6.7)
> 1.14 x 10-7 mol/L 719 (38.7) 718 (38.4) 1 (100) 712 (38.5) 7 (25.6) 715 (38.4) 4 (46.8)
Missing 2842 32 2810 26 2816 26 2816
Blood lead level
0.2-1.2 µg/dL 2008 (52.8) 771 (50.1) 1237 (55.6) 762 (50.2) 1246 (55.5) 769 (50.3) 1239 (55.4)
1.3-2.1 µg/dL 1265 (30.5) 522 (31.4) 743 (29.5) 516 (31.5) 749 (29.4) 519 (31.5) 746 (29.4)
> 2.1 µg/dL 862 (16.7) 369 (18.5) 493 (14.9) 363 (18.3) 499 (15.1) 363 (18.2) 499 (15.2)
Missing 537 199 338 198 339 197 340
Serum cotinine
Lower 50 (< 0.06 ng/ml) 1670 (42.9) 650 (41.3) 1020 (44.2) 638 (41.4) 1032 (44.0) 649 (41.6) 1021 (43.9)
Upper 50 (0.06-9.99 ng/mL) ng/ml) 2210 (54.5) 910 (55.7) 1300 (53.2) 902 (55.5) 1308 (53.4) 901 (55.3) 1309 (53.5)
≥ 10 ng/ml 91 (2.6) 35 (3.1) 56 (2.6) 35 (3.1) 56 (2.5) 35 (3.1) 56 (2.6)
Missing 701 266 435 264 437 263 438
Creatinine
< 92 mg/dL 1481 (37.2) 685 (38.8) 796 (34.7) 673 (38.6) 808 (34.9) 680 (38.6) 801 (34.9)
92-164 mg/dL 1742 (39.3) 717 (39.3) 1025 (39.1) 709 (39.3) 1033 (39.1) 713 (39.4) 1029 (39.0)
> 164 mg/dL 1276 (23.5) 459 (21.8) 817 (26.2) 457 (22.0) 819 (26.1) 455 (21.9) 821 (26.1)
Missing 173 0 173 0 173 0 173
Mother's age at birth
< 25 years 2215 (41.7) 861 (41.8) 1354 (41.4) 853 (41.9) 1362 (41.3) 856 (42.0) 1359 (41.3)
25–34 years 2015 (47.8) 836 (49.2) 1179 (47.1) 822 (49.0) 1193 (47.3) 829 (48.9) 1186 (47.3)
35+ years 373 (10.5) 135 (9.0) 238 (11.5) 135 (9.1) 238 (11.4) 135 (9.1) 238 (11.4)
Missing 69 29 40 29 40 28 41
Mother smoked during pregnancy
Yes 647 (18.3) 265 (18.7) 382 (18.1) 263 (18.7) 384 (18.1) 261 (18.7) 386 (18.1)
No 3952 (81.7) 1566 (81.3) 2386 (81.9) 1546 (81.3) 2406 (81.9) 1557 (81.3) 2395 (81.9)
Missing 73 30 43 30 43 30 43
aPercent values provided in parentheses are weighted.
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3-PBA (n = 1861)
Children without
3-PBA (n = 2811)
Children with
cis-DCCA (n = 1839)
Children without
cis-DCCA (n = 2833)
Children with
trans-DCCA (n = 1848)
Children without
trans-DCCA (n = 2824)
LD
Yes 544 (11.5) 223 (12.7) 321 (11.2) 221 (12.8) 323 (11.1) 221 (12.7) 323 (11.2)
No 4118 (88.5) 1636 (87.3) 2482 (88.8) 1616 (87.2) 2502 (88.9) 1625 (87.3) 2493 (88.8)
Missing 10 2 8 2 8 2 8
ADHD
Yes 342 (9.3) 148 (10.0) 194 (9.1) 146 (9.9) 196 (9.2) 147 (9.9) 195 (9.2)
No 4320 (90.7) 1708 (90.0) 2612 (90.9) 1688 (90.1) 2632 (90.8) 1697 (90.1) 2623 (90.8)
Missing 10 5 5 5 5 4 6
LD+ADHD
Yes 174 (4.3) 78 (5.4) 96 (3.8) 77 (5.4) 97 (3.8) 78 (5.4) 96 (3.8)
No 4479 (95.7) 1776 (94.6) 2703 (96.2) 1755 (94.6) 2724 (96.2) 1764 (94.6) 2715 (96.2)




     
              
         
       
       
       
            
       
       
       
          
       
       
       
            
       
       
       
          
       
       
       
            
       
       
       
          
       
       
       
            
        
       
       
          
       
       
       
            
       
       
       
 
     
 
Table S3. ORs for LD, ADHD, and both LD and ADHD for every 10-fold increase in urinary 3-PBA
concentrations including and excluding select variables as a covariates in the final models.a,b 
Neurodevelopmental outcome cOR (95% CI) p-value aOR (95% CI) p-value aORcreat (95% CI) p-value
Including PIR (n = 1551)
LD 1.18 (0.90, 1.56) 0.24 1.08 (0.80, 1.48) 0.61 1.00 (0.70, 1.41) 0.98
ADHD 1.18 (0.84, 1.66) 0.34 1.07 (0.74, 1.57) 0.72 0.98 (0.65, 1.46) 0.90
LD+ADHD 1.43 (0.86, 2.36) 0.17 1.24 (0.74, 2.07) 0.42 1.10 (0.64, 1.87) 0.73
Excluding PIR (n = 1551)
LD 1.18 (0.90, 1.56) 0.23 1.13 (0.83, 1.54) 0.43 1.04 (0.73, 1.48) 0.82
ADHD 1.18 (0.84, 1.66) 0.34 1.09 (0.76, 1.56) 0.65 0.99 (0.66, 1.46) 0.94
LD+ADHD 1.43 (0.86, 2.36) 0.17 1.32 (0.76, 2.28) 0.32 1.16 (0.65, 2.05) 0.62
Including total DAPs (n = 1652)
LD 1.27 (1.02, 1.58) 0.04 1.16 (0.90, 1.50) 0.25 1.11 (0.82, 1.49) 0.50
ADHD 1.26 (0.96, 1.64) 0.09 1.11 (0.81, 1.51) 0.52 1.05 (0.75, 1.46) 0.79
LD+ADHD 1.55 (1.04, 2.32) 0.03 1.33 (0.85, 2.08) 0.21 1.26 (0.78, 2.03) 0.34
Excluding total DAPs (n = 1652)
LD 1.27 (1.02, 1.58) 0.04 1.19 (0.93, 1.53) 0.17 1.11 (0.83, 1.49) 0.47
ADHD 1.26 (0.96, 1.64) 0.09 1.15 (0.85, 1.57) 0.36 1.06 (0.76, 1.47) 0.73
LD+ADHD 1.55 (1.04, 2.32) 0.03 1.45 (0.92, 2.26) 0.11 1.30 (0.82, 2.08) 0.26
Including blood lead (n = 1511)
LD 1.32 (1.07, 1.64) 0.01 1.23 (0.95, 1.59) 0.11 1.16 (0.87, 1.57) 0.31
ADHD 1.36 (1.05, 1.78) 0.02 1.24 (0.93, 1.64) 0.14 1.18 (0.87, 1.59) 0.30
LD+ADHD 1.78 (1.22, 2.58) 0.003 1.63 (1.01, 2.65) 0.05 1.49 (0.89, 2.51) 0.13
Excluding blood lead (n = 1511)
LD 1.32 (1.07, 1.64) 0.01 1.26 (0.97, 1.65) 0.09 1.20 (0.88, 1.64) 0.25
ADHD 1.36 (1.05, 1.78) 0.02 1.26 (0.94, 1.68) 0.12 1.20 (0.88, 1.64) 0.25
LD+ADHD 1.78 (1.22, 2.58) 0.003 1.74 (1.09, 2.78) 0.02 1.61 (0.99, 2.62) 0.06
Including serum cotinine (n = 1451)
LD 1.32 (1.07, 1.62) 0.01 1.24 (0.95, 1.61) 0.12 1.17 (0.87, 1.59) 0.30
ADHD 1.38 (1.05, 1.83) 0.02 1.27 (0.92, 1.76) 0.15 1.21 (0.85, 1.72) 0.28
LD+ADHD 1.77 (1.22, 2.57) 0.003 1.73 (1.08, 2.77) 0.02 1.60 (0.97, 2.63) 0.06
Excluding serum cotinine (n = 1451)
LD 1.32 (1.07, 1.62) 0.01 1.28 (0.98, 1.66) 0.07 1.21 (0.86, 1.65) 0.23
ADHD 1.38 (1.05, 1.83) 0.02 1.30 (0.95, 1.79) 0.10 1.24 (0.88, 1.75) 0.22
LD+ADHD 1.77 (1.22, 2.57) 0.003 1.78 (1.13, 2.81) 0.01 1.63 (1.00, 2.66) 0.05
Including all chemicals and PIR (n = 1333)
LD 1.28 (1.01, 1.61) 0.03 1.14 (0.85, 1.52) 0.39 1.05 (0.76, 1.46) 0.76
ADHD 1.32 (0.96, 1.81) 0.09 1.16 (0.81, 1.65) 0.42 1.11 (0.76, 1.60) 0.59
LD+ADHD 1.66 (1.11, 2.47) 0.01 1.33 (0.84, 2.13) 0.23 1.21 (0.76, 1.92) 0.43
Excluding all chemicals and PIR (n = 1333)
LD 1.28 (1.01, 1.61) 0.03 1.25 (0.94, 1.66) 0.12 1.16 (0.83, 1.61) 0.40
ADHD 1.32 (0.96, 1.81) 0.09 1.23 (0.88, 1.73) 0.23 1.16 (0.80, 1.68) 0.44
LD+ADHD 1.66 (1.11, 2.47) 0.01 1.65 (1.04, 2.61) 0.03 1.45 (0.91, 2.33) 0.12
Abbreviations: cOR=Crude odds ratio; aOR=Adjusted odds ratio; aORcreat=Adjusted odds ratio including urine
 
creatinine concentration as a covariate in the model.

aSample size for each model was based on the number of children with complete information on exposure, 

outcome, and covariates. bModels were adjusted for sex, age, race/ethnicity, household reference education 

level, low birth weight status, maternal age at child's birth, NICU admission, maternal smoking during 







        
   
   
      
        
     
    
   
       
   
   
   
       
   
  
      
Table S4. Pyrethroid metabolite descriptive statistics by NHANES cycle year for children 6 to 
15 years of age.
Pyrethroid metabolite Cycle year 1999-2000 Cycle year 2000-2001
3-PBA
N 841 1020
N (%) with detectable concentrations 623 (74.1) 811 (79.5)
GM (95% CI) (µg/L) 0.35 (0.24, 0.50) 0.29 (0.23, 0.38)
p-value comparing GMa 0.42
cis-DCCA
N 819 1020




N (%) with detectable concentrations 322 (38.7) 304 (30.0)
p-valueb 0.006
aT-test p-value comparing 3-PBA concentrations between cycle year. bChi-square p-value
comparing detection rates of cis- and trans-DCCA by cycle year.
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